Results 231 to 240 of about 77,746 (246)

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2014
Michael Manns, Maria Buti, Ewa Janczewska   +2 more
exaly  

Adjuvant therapy of colon cancer

Ca-A Cancer Journal for Clinicians, 1999
exaly  

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Lancet, The, 2008
Mario Santinami, Alessandro A E Testori, Reinhard Dummer   +2 more
exaly  

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Lancet, The, 2009
Talmadge E King Jr, Lisa H Lancaster, Michiel J Thomeer   +2 more
exaly  

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

Lancet, The, 2001
Giancarlo Comi, Massimo Filippi, Frederik Barkhof   +2 more
exaly  

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
exaly  

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Lancet, The, 2007
Ludwig Kappos, Mark S Freedman, H-P Hartung   +2 more
exaly  

Glatiramer-acetate/interferon-beta-1a

Reactions Weekly, 2022
openaire   +1 more source

Glatiramer-acetate/interferon-beta-1a

Reactions Weekly, 2020
openaire   +1 more source

Interferon-beta-1a/ocrelizumab

Reactions Weekly
openaire   +1 more source